Combination of oxaliplatin and capecitabine (CAPOX) in first and second-line treatment for metastatic colorectal carcinoma (MCRC).

被引：0
|
作者：
Lopez-Vivanco, G [1 ]
Muñoz, A [1 ]
Mañe, JM [1 ]
Ferreiro, J [1 ]
Rubio, I [1 ]
Fuente, N [1 ]
Perez-Hoyos, T [1 ]
Lopez-Argumedo, G [1 ]
Viteri, A [1 ]
Barcelo-Galindez, R [1 ]
机构：
[1] Hosp Cruces, Bilbao, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3701
引用
收藏
页码：294S / 294S
页数：1
相关论文
共 50 条
  • [41] Bi-weekly XELOX (capecitabine/oxaliplatin) plus bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC): PHOENIX trial
    Nagata, N.
    Okada, T.
    Okazaki, S.
    Sato, S.
    Kin, H.
    Nakamura, M.
    Kunieda, K.
    Oba, K.
    Sakamoto, J.
    Mishima, H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S559 - S559
  • [42] SECOND-LINE CHEMOTHERAPY AFTER FIRST-LINE IRINOTECAN, OXALIPLATIN AND 5-FU/LV (FOLFOXIRI) IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS (PTS)
    Marcucci, L.
    Cupini, S.
    Masi, G.
    Allegrini, G.
    Cerri, E.
    Loupakis, F.
    Ricci, S.
    Brunetti, I.
    Fontana, E.
    Falcone, A.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 60 - 60
  • [43] Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinoma
    Bullock, Andrea
    Stuart, Keith
    Jacobus, Susanna
    Abrams, Thomas
    Wadlow, Raymond
    Goldstein, Michael
    Miksad, Rebecca
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (06) : 945 - +
  • [44] Gemcitabine in combination with oxaliplatin as second-line therapy of advanced and metastatic NSCLC
    Alencar, A. J.
    Blaya, M.
    Raez, L.
    Farfan, N.
    Lopes, G.
    Walker, G.
    Flores, A.
    Macintyre, J.
    Rocha-Lima, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] CAPECITABINE AND OXALIPLATIN (CAPOX) PLUS CETUXIMAB IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA WHO PROGRESSED AFTER OXALIPLATIN-BASED CHEMOTHERAPY
    Petrovic, Z.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 135 - 135
  • [46] CAPECITABINE AND OXALIPLATIN (XELOX) COMBINATION CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER-A PHASE II STUDY
    Tawfik, Hesham
    El-Deen, Hanan Gamal
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 98 - 98
  • [47] Second-line treatment of metastatic prostatic carcinoma
    Newling, DWW
    [J]. UROLOGICAL RESEARCH, 1997, 25 (Suppl 2): : S73 - S78
  • [48] Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer
    Bayoglu, Ibrahim Vedat
    Varol, Umut
    Yildiz, Ibrahim
    Muslu, Ugur
    Alacacioglu, Ahmet
    Kucukzeybek, Yuksel
    Akyol, Murat
    Demir, Lutfiye
    Dirican, Ahmet
    Cokmert, Suna
    Yildiz, Yasar
    Karabulut, Bulent
    Uslu, Ruchan
    Tarhan, Mustafa Oktay
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (17) : 7119 - 7123
  • [49] Cost-effectiveness analysis (CEA) of bevacizumab (Bev) in first- and second-line treatment of metastatic colorectal cancer (mCRC)
    Goldstein, Daniel A.
    Chen, Qiushi
    Howard, David H.
    Lipscomb, Joseph
    Ayer, Turgay
    El-Rayes, Bassel F.
    Flowers, Christopher
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Second-line treatment of metastatic prostatic carcinoma
    D. W. W. Newling
    [J]. Urological Research, 1997, 25 : S73 - S78
12345